–IGNITE DMD clinical trial expected to resume dosing in the first quarter of 2021– -Collaboration with Ultragenyx creates opportunities to develop additional gene therapies for Duchene muscular dystrophy- – Enhanced cash position resulting from …
MINNEAPOLIS, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Tile Shop Holdings, Inc. (OTC Pink: TTSH) (the “Company”), a specialty retailer of natural stone and man-made tiles, setting and maintenance materials, and related accessories, today announced results for its …
Company reports third quarter 2020 XHANCE net revenue of $15.4 million New prescriptions of XHANCE increased 23% from second quarter 2020 Conference call and webcast to be held today at 8:00 a.m. Eastern Time YARDLEY, Pa., Nov. 05, 2020 (GLOBE NEWSWIRE) -- …
Leading Phoenix-Area Property Owner to Host Monthly Luxury Event “There's a point at 7,000 RPM where everything fades. The machine becomes weightless. It just disappears. All that's left, a body moving through space and time. 7,000 RPM, that's …
FDA accepted and granted priority review of NDA for Oral Paclitaxel in metastatic breast cancer PDUFA dates for tirbanibulin ointment and Oral Paclitaxel set for December 30, 2020 and February 28, 2021, respectively Four abstracts featuring Oral Paclitaxel …
BANNOCKBURN, Ill., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Stericycle, Inc. (Nasdaq: SRCL) today reported results for the third quarter ended September 30, 2020. Revenues for the quarter were $636.4 million, a decrease of 23.6% compared to $833.1 million in the …
MISSISSAUGA, Ontario, Nov. 05, 2020 (GLOBE NEWSWIRE) -- KP Tissue Inc. (KPT) (TSX: KPT) reports the Q3 2020 financial and operational results of KPT and Kruger Products L.P. (KPLP). Kruger Products is Canada's leading manufacturer of quality tissue …
Galafold 3Q20 Revenue of $67.4 Million, On-Track to Achieve Revenue Guidance of $250M-$260M AT-GAA Phase 3 PROPEL Study Readout in 1Q21 and Rolling BLA Submission to Begin in 4Q20 Positive CLN6 Batten Disease Gene Therapy Data Presented in October Fabry …
- Total revenues of $15.7 million and net product revenues of $5.8 million - - Sequential quarterly increase in underlying customer demand of over 120% for DEXYCU® and over 5% for YUTIQ® - - EYP-1901, a potential six-month sustained delivery intravitreal …
CB2 enters into binding Letter of Intent to acquire APEX Family Medical. APEX generated over CAD 2.5 million in revenues in fiscal 2019 and CAD 0.5 million in net income. Currently services over 5,000 patients in the Greater Denver area, with over 30 years …
SAN DIEGO, Nov. 05, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced that it will report third quarter …
COMET Phase 3 long-term safety trial of AXS-05 in MDD, and MOVEMENT Phase 3 long-term safety trial of AXS-07 in migraine completed NDA submissions for AXS-05 in depression expected in January 2021, and for AXS-07 in migraine expected in 1Q 2021 Launch …
MIAMI, FL, Nov. 05, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce preliminary topline performance …
NICOSIA, Cyprus, Nov. 05, 2020 (GLOBE NEWSWIRE) -- QIWI plc, (NASDAQ: QIWI) (MOEX: QIWI) (“QIWI” or the “Company”) today announced that it will host a conference call and webcast on Thursday, November 19, 2020 at 8:30 a.m. ET to review the third quarter …
TEL AVIV, Israel and RALEIGH, N.C., Nov. 05, 2020 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced that it will report its third-quarter 2020 financial results …
LONDON, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced its operational and financial results for the third …
Third Quarter 2020 Highlights: Consolidated Revenues of $317 million Vonage Communications Platform (VCP) Revenues of $234 million VCP Service Revenues increased 19% API Revenues Increased 35% Unified Communications & Contact Center Service Revenues …
Third quarter revenue of $352M on stable shipment volumes Completion of $20M run-rate savings from reorganization actions deliver 13% decremental margins Net Income turns positive with $0.07 GAAP EPS or $0.09 adjusted non-GAAP EPS Substantial improvement …
Dallas, Texas, Nov. 05, 2020 (GLOBE NEWSWIRE) -- The “Global Composites Market Size 2018, by Fiber Type (Glass Fiber Composites, Carbon Fiber Composites, Natural Fiber Composites), Resin Type (Thermoset Composites, Thermoplastic Composites), Manufacturing …
Banca Ifis: net profit for the nine months reaches the targets envisaged for year end Despite the fact that the macroeconomic scenario continues to be uncertain and the general situation difficult, the Bank continues to operate efficiently and with great …
06 days 22:37:18
